The Travel Vaccines Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Travel Vaccines Market:
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report
According to The Business Research Company’s Travel Vaccines Global Market Report 2024, The travel vaccines market size has grown strongly in recent years. It will grow from $4.41 billion in 2023 to $4.79 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increased international travel, government initiatives for travel health, globalization of diseases, growing awareness among travelers, expansion of travel and tourism industry..
The travel vaccines market size is expected to see strong growth in the next few years. It will grow to $6.79 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing frequency of business travel, emerging infectious disease threats, government regulations and entry requirements, rising demand for exotic destinations, collaboration between governments and pharmaceutical companies.. Major trends in the forecast period include tailored vaccination strategies, expansion of market to non-endemic regions, adoption of digital health technologies, regulatory support and streamlined approvals, innovative developments.
The increase in travel and tourism is expected to propel the growth of the travel vaccine market going forward. Travel and tourism refer to the movement of people or things, including vehicles like trains, boats, airplanes, and other conveyances, between various remote geographic areas. Travel vaccines are helpful for tourists and travelers by keeping them safe and healthy while they are traveling abroad. For instance, in January 2023, according to the United Nations World Tourism Organization (UNWTO), a Spain-based intergovernmental tourism-promoting organization, more than 900 million tourists traveled abroad in 2022, double the amount recorded in 2021 but still 63% higher than pre-pandemic levels. Therefore, the increase in travel and tourism is driving the growth of the travel vaccine market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp
The travel vaccines market covered in this report is segmented –
1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel
Top Major Players:
Pfizer Inc.
Johnson and Johnson
Merck & Co. Inc.
Novartis AG
Sanofi SA
North America was the largest region in the travel vaccines market in 2023.
Product innovation is a key trend gaining popularity in the travel vaccine market. Major companies operating in the travel vaccine market are developing innovative vaccines sustain their position in the market. For instance, in August 2022, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, got the approval for QDENGA (Dengue Tetravalent Vaccine) (TAK-003), for the prevention of dengue sickness caused by any serotype in people aged six to 45 from Indonesia National Agency for Drug and Food Control. Regardless of a person’s prior exposure to the disease, QDENGA showed three years after immunization that it remained to provide overall protection against dengue sickness and hospitalization.
The travel vaccines market report table of contents includes:
1. Executive Summary
2. Travel Vaccines Market Characteristics
3. Travel Vaccines Market Trends And Strategies
4. Travel Vaccines Market – Macro Economic Scenario
5. Global Travel Vaccines Market Size and Growth
…
32. Global Travel Vaccines Market Competitive Benchmarking
33. Global Travel Vaccines Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Travel Vaccines Market
35.Travel Vaccines Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope The adhesives refer to products such as glues, and caulking compounds that…
Overview and Scope Adalimumab, infliximab, and etanercept biosimilars refer to a novel class of medications…
Overview and Scope Acne drugs refer to medications that aid in the treatment of acne…
Overview and Scope Accounting services are defined as services used for the measurement, processing, and…
Overview and Scope 5G is the fifth generation of broadband or cellular technology designed to…
Overview and Scope Industrial tourism refers to the idea of visiting locations connected to the…